Delivering Peptides to the Central Nervous System: Dilemmas and Strategies

Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists

Volumn 8, Issue 11, 1991, Pages 1345-1350

  Banks, William A ^a,b   Kastin, Abba J ^a   Barrera, Carlos M ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

blood brain barrier; cell membrane; drug design; drug therapy; opiates; transport

Indexed keywords

ARGIPRESSIN; CYCLOSPORIN A; DELTA SLEEP INDUCING PEPTIDE; DRUG CARRIER; ENKEPHALIN DERIVATIVE; GONADORELIN; HORMONE; LEUCINE ENKEPHALIN; NALOXONE; NALTREXONE; OPIATE; OXYTOCIN; PEPTIDE; PROTIRELIN; SOMATOSTATIN;

BLOOD BRAIN BARRIER; CELL MEMBRANE; CENTRAL NERVOUS SYSTEM; DIFFUSION; DRUG DESIGN; DRUG PENETRATION; DRUG TARGETING; DRUG TRANSPORT; HUMAN; NONHUMAN; REVIEW;

BLOOD-BRAIN BARRIER; BRAIN; HUMAN; PEPTIDES; SUPPORT, U.S. GOV'T, NON-P.H.S.;

EID: 0025955822     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1023/A:1015884603456     Document Type: Review

References (70)

1. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data
2. The unit impulse response procedure for the pharmacokinetic evaluation of drug entry into the central nervous system
3. High and low affinity transport of {s cd}-glucose from blood to brain
4. An in situ brain perfusion technique to study cerebrovascular transport in the rat
5. Passage of Tyr-MIF-1 from blood to brain
6. Slow penetration of thyrotropin-releasing hormone across the blood-brain barrier of an in situ perfused guinea pig brain
7. Quantifying carrier-mediated transport of peptides from the brain to the blood
8. Characterization of an in vitro blood-brain barrier model for studying drug transport and metabolism
9. Bidirectional transport of interleukin-1 alpha across the blood-brain barrier
10. Blood to brain transport of interleukin links the immune and central nervous systems
11. Receptor-mediated transcytosis of transferrin across the blood-brain barrier
12. Studies of the slow bidirectional transport of iron and transferrin across the blood-brain barrier
13. Immunoneurology: A serum protein afferent limit to the CNS
14. 125I-prolactin in preterm rabbits
15. Changes in regional blood-brain transfer of l-leucine elicited by arginine-vasopressin
16. Delta sleep-inducing peptide crosses the blood-brain barrier in dogs: Some correlations with protein binding
17. Entry of DSIP peptides into the dog CSF: Role of physicochemical and pharmacokinetic parameters
18. 125I-Tyr-MIF-l from the rat brain after icv injection
19. The transport of α-aminoisobutyric acid across brain capillary and cellular membranes
20. Low permeability of the blood-brain barrier to nanomolar concentrations of immunoreactive alpha-melanotropin
21. 125I-N-Tyr-delta sleep-inducing peptide crosses the blood-brain barrier by a non-competitive mechanism
22. Saturable mechanism for delta sleep-inducing peptide (DSIP) at the blood-brain barrier of the vascularly perfused guinea pig brain
23. Peptides and the blood-brain barrier: Lipophilicity as a predictor of permeability
24. Permeability of the blood-brain barrier to the immunosuppressive cyclic peptide cyclosporin A
25. Transport of vasopressin fragments across the blood-brain barrier: In vitro studies using monolayer cultures of bovine brain endothelial cells
26. The transport of encephalins from the cerebrospinal fluid of the rabbit
27. Minireview: Saturable transport of peptides across the blood-brain barrier
28. Carrier-mediated transport of enkephalins and N-Tyr-MIF-1 across the blood-brain barrier
29. Carrier-mediated transport of vasopressin across the blood-brain barrier of the mouse
30. Carrier-mediated transport of labeled oxytocin from brain to blood
31. Transport of leucine-enkephalin across the blood-brain barrier in the perfused guinea-pig brain
32. Effect of neurotransmitters on the system that transports Tyr-MIF-1 and the enkephalins across the blood-brain barrier: A dominant role for serotonin
33. Editorial Review: Peptide transport systems for opiates across the blood-brain barrier
34. Stereospecific transport of Tyr-MIF-1 across the blood-brain barrier by peptide transport system-1
35. 1]-Peptide T-amide is transported from the blood to the brain by a saturable system
36. LHRH crosses the blood-brain barrier from brain to blood by a saturable system
37. The bi-directional saturable transport of LHRH across the blood-brain barrier
38. Passage of delta sleep-inducing peptide (DSIP) across the blood-cerebrospinal fluid barrier
39. Potential for pharmacologic manipulation of the blood-cerebrospinal fluid barrier
40. Differential effects of acetazolamide, benzolamide and systemic acidosis on hydrogen and bicarbonate gradients across the apical and basolateral membranes of the choroid plexus
41. The anatomic basis of the blood-brain barrier
42. Accumulation of peptides by choroid plexus in vitro: Tyr-D-Ala-Gly as a model
43. 3H-L-prolyl-L-leucylglycinamide
44. 3H-α-MSH in rat brain
45. 1-γ-endorphin (DTγE) and des-enkephalin-γ-endorphin (DEγE): Plasma profile and brain uptake after systemic administration in the rat
46. Penetration of neurohypophyseal hormones from plasma into cerebrospinal fluid (CSF): Half-times of disappearance of these neuropeptides from CSF
47. Permeability of the blood-brain barrier to neuropeptides: The case for penetration
48. In vivo fate of a behaviorally active ACTH 4–9 analog in rats after systemic administration
49. Transport of desglycinamidearginine vasopressin across the blood-brain barrier in rats as evaluated by the unit impulse response methodology
50. Lipid solubility and drug penetration of the blood-brain barrier
51. Neuroendocrine aspects of circumventricular organs
52. Relations between leptomeningeal compartments and the neurohemal regions of circumventricular organs
53. Effect of indomethacin on febrile response to recombinant human interleukin-lα in rabbits
54. Sleep-wave activity of a delta sleep-inducing peptide analog correlates with its penetrance of the blood-brain barrier
55. Recent advances in blood-brain transport
56. Expanding the definition of the blood-brain barrier to protein
57. Adsorptive endocytosis and membrane recycling by cultured primary bovine brain microvessel endothelial cell monolayers
58. Review: Transcytosis of macromolecules through the blood-brain barrier: A cell biological perspective and critical appraisal
59. Review: Interactions between the blood-brain barrier and endogenous peptides: Emerging clinical implications
60. Permeability of the murine blood-brain barrier to some octapeptide analogs of somatostatin
61. Inhibition of the brain to blood transport system for enkephalins and Tyr-MIF-1 in mice addicted or genetically predisposed to drinking ethanol
62. Reduction in cerebral methionine-enkephalin content during the ethanol withdrawal syndrome
63. Ethanol acceptance as a function of genotype amounts of brain [Met]enkephalin
64. Modulation of the carriermediated transport of Tyr-MIF-1 across the blood-brain barrier by essential amino acids
65. Delta sleep-inducing peptide is absorbed by the gastrointestinal tract of the neonatal rat
66. Neonatal administration of met-enkephalin facilitates maze performance of adult rats
67. Developmental, behavioral, and opiate receptor changes after prenatal or postnatal (β-endorphin, CRF, or Tyr-MIF-1
68. Influence of neonatal injections of α-MSH on learning, memory and attention in rats
69. Aluminum-induced neurotoxicity: Alterations in membrane function at the blood-brain barrier
70. Entry of opioid peptides into the central nervous system